MYC and acute lymphoblastic leukemia: For example THZ1, a covalent CDK7 inhibitor, has been shown to abrogate MYC-enhancer aberrant contacts (44) and deter growth in T-ALL cell lines (60), potentially accounting for the anti-tumoral effect of these small-molecule inhibitors.